- Home
- LSTA vs SCNX Comparison
LSTA vs SCNX Comparison
Compare LSTA & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSTA | SCNX |
|---|---|---|
| Founded | 1980 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9M | 16.2M |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | LSTA | SCNX |
|---|---|---|
| Price | $1.50 | $0.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $15.00 | $1.50 |
| AVG Volume (30 Days) | 315.7K | ★ 594.3K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.42 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,283,868.00 | $3,831,778.00 |
| Revenue This Year | N/A | $1,097.38 |
| Revenue Next Year | N/A | $239.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 56.90 | 30.72 |
| 52 Week Low | $0.99 | $0.24 |
| 52 Week High | $5.07 | $2.60 |
Technical Indicators
Market Signals| Indicator | LSTA | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 23.16 |
| Support Level | N/A | $0.24 |
| Resistance Level | N/A | $0.43 |
| Average True Range (ATR) | 0.00 | 0.02 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 0.77 |
Price Performance
Historical ComparisonAbout LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.